论文部分内容阅读
乳腺癌已被公认为是一种全身性疾病,是女性最常见的恶性肿瘤之一,其发病率逐年增高,发病年龄有提早的倾向。作者对60例乳腺癌手术病人,用免疫组化法检测,结合临床分期、病理类型,并随访6个月~5年,初探CD44V6、ER、CerbB-2表达与乳腺癌预后的关系。1资料与方法1·1一般资料收集?
Breast cancer has been recognized as a systemic disease, is one of the most common malignant tumors in women, the incidence increased year by year, the age of onset has an earlier trend. The authors studied the relationship between the expression of CD44V6, ER and CerbB-2 and the prognosis of breast cancer in 60 patients with breast cancer who were examined by immunohistochemistry, clinical stages and pathological types and followed up for 6 months to 5 years. 1 Materials and Methods 1.1 General Information Collection?